Olanzapine for Acute Headaches

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 17, 2018

Study Completion Date

May 20, 2018

Conditions
Headache
Interventions
DRUG

Standard of Care as per attending physician

Patients are randomized to standard of care medication (as determined by attending physician)

DRUG

5mg rapidly dissolving olanzapine

5mg rapidly dissolving olanzapine

Trial Locations (1)

55101

Regions Hospital, Saint Paul

All Listed Sponsors
lead

HealthPartners Institute

OTHER

NCT03066622 - Olanzapine for Acute Headaches | Biotech Hunter | Biotech Hunter